Groupama Asset Managment Legend Biotech Corp Transaction History
Groupama Asset Managment
- $7.37 Trillion
- Q2 2024
A detailed history of Groupama Asset Managment transactions in Legend Biotech Corp stock. As of the latest transaction made, Groupama Asset Managment holds 22,782 shares of LEGN stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,782
Previous 21,422
6.35%
Holding current value
$1.08 Million
Previous $1.2 Billion
16.02%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$546 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$356 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$315 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$272 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$227 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.95B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...